Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection

NCT01308424 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

Oral Herpes Simplex

Interventions

DRUG: BTL TML HSV
DRUG: Matching placebo

Sponsor

Beech Tree Labs, Inc.

Collaborators

[object Object]